Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow JapaneseTranslation
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibbons, C. H.
Right arrow Articles by Freeman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibbons, C. H.
Right arrow Articles by Freeman, R.
Related Collections
Right arrow Autonomic diseases
Right arrow Peripheral neuropathy
NEUROLOGY 2009;72:1479-1486
© 2009 American Academy of Neurology

Quantification of sweat gland innervation

A clinical–pathologic correlation

Christopher H. Gibbons, MD, MMSc, Ben M. W. Illigens, MD, Ningshan Wang, PhD and Roy Freeman, MD

From the Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Address correspondence and reprint requests to Dr. Roy Freeman, Autonomic and Peripheral Nerve Laboratory, Department of Neurology, Beth Israel Deaconess Medical Center, 1 Deaconess Road, Boston, MA 02215 rfreeman{at}bidmc.harvard.edu

Objective: To evaluate a novel method to quantify the density of nerve fibers innervating sweat glands in healthy control and diabetic subjects, to compare the results to an unbiased stereologic technique, and to identify the relationship to standardized physical examination and patient-reported symptom scores.

Methods: Thirty diabetic and 64 healthy subjects had skin biopsies performed at the distal leg and distal and proximal thigh. Nerve fibers innervating sweat glands, stained with PGP 9.5, were imaged by light microscopy. Sweat gland nerve fiber density (SGNFD) was quantified by manual morphometry. As a gold standard, three additional subjects had biopsies analyzed by confocal microscopy using unbiased stereologic quantification. Severity of neuropathy was measured by standardized instruments including the Neuropathy Impairment Score in the Lower Limb (NIS-LL) while symptoms were measured by the Michigan Neuropathy Screening Instrument.

Results: Manual morphometry increased with unbiased stereology (r = 0.93, p < 0.01). Diabetic subjects had reduced SGNFD compared to controls at the distal leg (p < 0.001), distal thigh (p < 0.01), and proximal thigh (p < 0.05). The SGNFD at the distal leg of diabetic subjects decreased as the NIS-LL worsened (r = –0.89, p < 0.001) and was concordant with symptoms of reduced sweat production (p < 0.01).

Conclusions: We describe a novel method to quantify the density of nerve fibers innervating sweat glands. The technique differentiates groups of patients with mild diabetic neuropathy from healthy control subjects and correlates with both physical examination scores and symptoms relevant to sudomotor dysfunction. This method provides a reliable structural measure of sweat gland innervation that complements the investigation of small fiber neuropathies.

Abbreviations: AOI = area of interest; CI = confidence interval; ICC = intraclass correlation coefficient; IENFD = intraepidermal nerve fiber density; IgG = immunoglobulin G; NIS-LL = Neuropathy Impairment Score in the Lower Limb; PLP = paraformaldehyde-lysine-periodate; QSART = quantitative sudomotor axon reflex test; SGNFD = sweat gland nerve fiber density; TH = tyrosine hydroxylase.


Supplemental data at www.neurology.org

Supported by the Juvenile Diabetes Research Foundation 11-2007-143, NIH K23NS050209, the Langer Family Foundation, and the Harriet Lewis Foundation.

Disclosure: The authors report no disclosures.

Medical Devices: BH-2 trinocular head microscope (Olympus, Center Valley, PA); PixeLINK PL-686 (PixeLINK, Ottawa, ON); Zeiss LSM Pascal Exciter (Carl Zeiss, Thornwood, NY).

Received September 19, 2008. Accepted in final form February 2, 2009.




This article has been cited by other articles:


Home page
JWatch NeurologyHome page
Reduced Innervation of Sweat Glands in Diabetic Neuropathy
Journal Watch Neurology, July 21, 2009; 2009(721): 2 - 2.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by AAN Enterprises, Inc.